UNSPSC 51381501: Colfenamate

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H13F3N2O3, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier N0V0Q7845W, chemically known as n-(alpha, alpha, alpha-trifluoro-m-tolyl)anthranilic acid, ester with glycolamide. but more generally known as colfenamate, which bears U.S. National Institutes of Health Compound Identifier 198806. The European Medicines Agency schedules Colfenamate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06797MIG.

The term COLFENAMATE is an International Non-Proprietary Name. COLFENAMATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: FC(F)(F)C1CC(NC2C(CCCC2)C(=O)OCC(=O)N)CCC1.

UNSPSC 51381501 Colfenamate is a Commodity code that nominally covers a nonsteroidal anti-inflammatory drug (NSAID), yet the recent state and local procurement activity under this code shows a significant mismatch: the single recent opportunity on record is Seminole County, Florida's solicitation for Naloxone and drug deactivation systems, which are opioid-overdose reversal agents and harm-reduction equipment wholly unrelated to colfenamate's pharmaceutical scope. State and local governments do not appear to be actively procuring colfenamate as a line item under this code at present. The Seminole County IFB (IFB60459723LAS) indicates that when this code is used, the actual buying focuses on emergency medical countermeasures and public-health response supplies rather than anti-inflammatory medications.

The geographic activity is confined to Florida based on available records. Seminole County is the sole identified issuing body in the recent-opportunities block, and the procurement was posted June 30, 2026, with a response deadline of July 26, 2023 — a date that appears inconsistent with the post date and likely reflects a data entry error in the source. The contract calls for annual delivery of 1,900 units of Naloxone and 800 safe drug deactivation systems on a quarterly basis to the Seminole County Community Health Building in Sanford, under a two-year term with one-year renewal option. The IFB requires E-Verify compliance, drug-free workplace certification, and standard insurance coverage; potential FEMA funding introduces federal environmental-compliance requirements. This code does not show active procurement volume or repeat buyer patterns sufficient to support a sustained business development strategy.